Differential effects of PDGF-BB on matrix metalloproteases and cytokine release in fibroblasts of Type 2 diabetic patients and normal controls in vitro

Journal of Diabetes and its Complications - Tập 20 - Trang 105-112 - 2006
Ralf Lobmann1, Thomas Pap2, Andreas Ambrosch3, Katrin Waldmann1, Wolfgang König3, Hendrik Lehnert1
1Department of Endocrinology and Metabolism, Magdeburg University Medical School, Magdeburg 39120, Germany
2Institute of Experimental Rheumatology, Magdeburg University Medical School, Magdeburg 39120, Germany
3Department of Clinical Microbiology, Magdeburg University Medical School, Magdeburg 39120, Germany

Tài liệu tham khảo

Armstrong, 2002, The role of matrix metalloproteinases in wound healing, Journal of the American Podiatric Medical Association, 92, 12, 10.7547/87507315-92-1-12 Beer, 1997, Reduced expression of PDGF and PDGF receptors during impaired wound healing, Journal of Investigative Dermatology, 109, 132, 10.1111/1523-1747.ep12319188 Bullen, 1995, Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds, Journal of Investigative Dermatology, 104, 236, 10.1111/1523-1747.ep12612786 Burstein, 1987, Growth factor effects on corneal wound healing, Journal of Ocular Pharmacology, 3, 263, 10.1089/jop.1987.3.263 Calel, 1987, Human epidermal growth factor—The influence on the healing of surgically closed corneal wounds, Acta Ophthalmologica Suppl, 182, 58 Canturk, 1999, Effects of granulocyte-macrophage colony-stimulating factor on incisional wound healing in an experimental diabetic rat model, Endocrine Research, 25, 105, 10.3109/07435809909066133 Eming, 1995, Journal of Investivestigative Dermatology, 105, 756, 10.1111/1523-1747.ep12325550 Fedyk, 2001, Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing, Journal of Immunology, 166, 5749, 10.4049/jimmunol.166.9.5749 Froget, 2003, Wound healing mediator production by human dermal fibroblasts grown within a collagen–GAG matrix for skin repair in humans, European Cytokine Network, 14, 60 Gailit, 1994, Wound repair in the context of extracellular matrix, Current Opinion in Cell Biology, 6, 717, 10.1016/0955-0674(94)90099-X Greenhalgh, 1996, The role of growth factors in wound healing, Journal of Trauma, 41, 159, 10.1097/00005373-199607000-00029 Greenhalgh, 1990, PDGF and FGF stimulate wound healing in the genetically diabetic mouse, American Journal of Pathology, 136, 1235 Groves, 2000, Recombinant human GM-CSF in the treatment of poorly healing wounds, Advances in Skin and Wound Care, 13, 107 Han, 2001, Transforming growth factor-beta- and tumor necrosis factor-alpha-mediated induction and proteolytic activation of MMP-9 in human skin, Journal of Biological Chemistry, 276, 22341, 10.1074/jbc.M010839200 Han, 2001, TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP, Journal of Cell Science, 114, 131, 10.1242/jcs.114.1.131 Holloway, 1993, A randomized, controlled, multicenter, dose response trial of activated platelet supernatant, topical CT-102 in chronic, non-healing, diabetic wounds, Wounds, 5/4, 198 Hosokawa, 2000, Controlled local application of basic fibroblast growth factor (FGF-2) accelerates the healing of GBR. An experimental study in beagle dogs, Clinical Oral Implants Research, 11, 345, 10.1034/j.1600-0501.2000.011004345.x Juhasz, 1993, Regulation of extracellular matrix proteins and integrin cell substratum adhesion receptors on epithelium during cutaneous human wound healing in vivo, American Journal of Pathology, 143, 1458 Kähäri, 1997, Matrix metalloproteinases in skin, Experimental Dermatology, 6, 199, 10.1111/j.1600-0625.1997.tb00164.x Ladin, 2000, Becaplermin gel (PDGF-BB) as topical wound therapy. Plastic Surgery Educational Foundation DATA Committee, Plastic and Reconstructive Surgery, 105, 1230, 10.1097/00006534-200003000-00065 Ladwig, 2002, Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers, Wound Repair and Regeneration, 10, 26, 10.1046/j.1524-475X.2002.10903.x Lee, 2000, Inhibition of tumor necrosis factor-alpha attenuates wound breaking strength in rats, Wound Repair and Regeneration, 8, 547, 10.1046/j.1524-475x.2000.00547.x Lobmann, 2002, Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients, Diabetologia, 45, 1011, 10.1007/s00125-002-0868-8 Lobmann, 2005, Proteases and the diabetic foot syndrome: Mechanisms and therapeutic implications, Diabetes Care, 28, 461, 10.2337/diacare.28.2.461 Lynch, 1987, Role of platelet-derived growth factor in wound healing: Synergistic effects with other growth factors, Proceedings of the National Academy of Sciences of the United States of America, 84, 7696, 10.1073/pnas.84.21.7696 Mandracchia, 2001, The use of becaplermin (rhPDGF-BB) gel for chronic nonhealing ulcers. A retrospective analysis, Clinics in Podiatric Medicine and Surgery, 18, 189 Mast, 1996, Interactions of cytokines, growth factors and proteasesin acute and chronic wounds, Wound Repair and Regeneration, 4, 420, 10.1046/j.1524-475X.1996.40404.x Moyer, 2002, Effects of interleukin-8 on granulation tissue maturation, Journal of Cellular Physiology, 193, 173, 10.1002/jcp.10160 Mun-Bryce, 1998, Gelatinase B modulates selective opening of the blood–brain barrier during inflammation, American Journal of Physiology, 274, R1203 Mustoe, 1987, Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta, Science, 237, 1333, 10.1126/science.2442813 Nwomeh, 2001, MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers, Journal of Surgical Research, 81, 189, 10.1006/jsre.1998.5495 Parkar, 2001, Expression of growth-factor receptors in normal and regenerating human periodontal cells, Archives of Oral Biology, 46, 275, 10.1016/S0003-9969(00)00099-6 Parsons, 1997, Matrix metalloproteinase, British Journal of Surgery, 84, 160, 10.1002/bjs.1800840206 Payne, 2001, Long-term outcome study of growth factor-treated pressure ulcers, American Journal of Surgery, 181, 81, 10.1016/S0002-9610(00)00536-5 Pierce, 1991, Quantitative analysis of inflammatory cell influx, procollagen type I synthesis, and collagen cross-linking in incisional wounds: Influence of PDGF-BB and TGF-beta 1 therapy, Journal of Laboratory and Clinical Medicine, 117, 373 Pierce, 1991, Role of platelet-derived growth factor in wound healing, Journal of Cellular Biochemistry, 45, 319, 10.1002/jcb.240450403 Pierce, 1995, Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF in chronic nonhealing wounds, Journal of Clinical Investigation, 96, 1336, 10.1172/JCI118169 Pierce, 1991, Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds, American Journal of Pathology, 138, 629 Porras-Reyes, 1991, Collagenase production at the border of granulation tissue in a healing wound: Macrophage and mesenchymal collagenase production in vivo, Connective Tissue Research, 27, 63, 10.3109/03008209109006995 Quaglino, 1990, Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: I. Excisional wound model, Laboratory Investigation, 63, 307 Ravanti, 2000, Matrix metalloproteinases in wound repair, International Journal of Molecular Medicine, 6, 391 Robson, 1992, Platelet-derived growth factor BB for the treatment of chronic ulcers, Lancet, 339, 23, 10.1016/0140-6736(92)90143-Q Saarialho-Kere, 1994, Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds, Journal of Clinical Investigation, 94, 79, 10.1172/JCI117351 Sasaki, 2000, Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, interleukin-1beta and TNF-alpha, Mediators of Inflammation, 9, 155, 10.1080/09629350020002895 Schultz, 1987, Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor, Science, 235, 350, 10.1126/science.3492044 Shigeyama, 2000, Expression of osteoclast differentiation factor in rheumatoid arthritis, Arthritis and Rheumatism, 43, 2523, 10.1002/1529-0131(200011)43:11<2523::AID-ANR20>3.0.CO;2-Z Singer, 1999, Cutaneous wound healing, New England Journal of Medicine, 341, 738, 10.1056/NEJM199909023411006 Steed, 1995, Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group, Journal of Vascular Surgery, 21, 71, 10.1016/S0741-5214(95)70245-8 Stricklin, 1993, Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds, American Journal of Pathology, 143, 1657 Trengove, 2000, Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers, Wound Repair and Regeneration, 8, 13, 10.1046/j.1524-475x.2000.00013.x Trengove, 1999, Analysis of the acute and chronic wound environments: The role of proteases and their inhibitors, Wound Repair and Regeneration, 7, 442, 10.1046/j.1524-475X.1999.00442.x Uemura, 2001, Diabetes mellitus enhances vascular matrix metalloproteinase activity: Role of oxidative stress, Circulation Research, 88, 1291, 10.1161/hh1201.092042 Vaalamo, 1999, Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing, Human Pathology, 30, 795, 10.1016/S0046-8177(99)90140-5 Vaalamo, 1997, Distinct populations of stromal cells express collagenase-3 (MMP-13) and COllagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds, Journal of Investigative Dermatology, 109, 96, 10.1111/1523-1747.ep12276722 Vaalamo, 1996, Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds, British Journal of Dermatology, 135, 52, 10.1111/j.1365-2133.1996.tb03607.x Wang, 2000, Molecular and cell biology of skin wound healing in a pig model, Connective Tissue Research, 41, 195, 10.3109/03008200009005290 Wieman, 1998, Clinical efficacy of becaplermin (rhPDGF-BB) gel. Becaplermin Gel Studies Group, American Journal of Surgery, 176, 74S, 10.1016/S0002-9610(98)00185-8 Wysocki, 1993, Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9, Journal of Inverstigative Dermatology, 101, 64, 10.1111/1523-1747.ep12359590 Zhang, 2002, Expression of integrins and MMPs during alkaline-burn-induced corneal angiogenesis, Investigative Ophthalmology & Visual Science, 43, 955